guidelines:
  1: Cytokine_Release_Syndrome_CRS_Grading.v1
test_cases:
- id: Grade 1 
  input:
    1:
      gt0003|Toxicity: local::at0003|Symptoms not life-threatening; only symptomatic treatment required (fever, nausea, fatigue, headache, myalgias, malaise)|
  expected_output:
    1:
      gt0005|Treatment: local::at0009|Vigilant supportive care, assess for infection (treat fever and neutropenia if present; monitor fluid balance; give antipyretics/analgesics as needed)|
      gt0006|Grade: local::at0014|Grade 1 CRS|

- id: Grade 1 and no effect of extensive comorbidities etc.
  input:
    1:
      gt0003|Toxicity: local::at0003|Symptoms not life-threatening; only symptomatic treatment required (fever, nausea, fatigue, headache, myalgias, malaise)|
      gt0012|Extensive comorbidities or older age: local::at0021|Yes|
  expected_output:
    1:
      gt0005|Treatment: local::at0009|Vigilant supportive care, assess for infection (treat fever and neutropenia if present; monitor fluid balance; give antipyretics/analgesics as needed)|
      gt0006|Grade: local::at0014|Grade 1 CRS|

- id: Grade 2 no comorbidities or old age
  input:
    1:
      gt0003|Toxicity: 'local::at0004|Moderate intervention required for response: oxygen requirement <40%, hypotension responsive to fluids, low dose of one pressor, or grade 2 organ toxicity|'
      gt0012|Extensive comorbidities or older age: local::at0020|No|
  expected_output:
    1:
      gt0005|Treatment: local::at0010|Vigilant supportive care (monitor cardiac and other organ function closely)|
      gt0006|Grade: local::at0015|Grade 2 CRS, no extensive comorbidities or older age|

- id: Grade 2 and comorbidities or old age
  input:
    1:
      gt0003|Toxicity: 'local::at0004|Moderate intervention required for response: oxygen requirement <40%, hypotension responsive to fluids, low dose of one pressor, or grade 2 organ toxicity|'
      gt0012|Extensive comorbidities or older age: local::at0021|Yes|
  expected_output:
    1:
      gt0005|Treatment: local::at0011|Vigilant supportive care, tocilizumab +/- corticosteroids|
      gt0006|Grade: local::at0016|Grade 2 CRS with extensive comorbidities or older age|

- id: Grade 3
  input:
    1:
      gt0003|Toxicity: 'local::at0005|Aggressive intervention required for response: oxygen requirement â‰¥40%, hypotension requiring high dose/multiple pressors, grade 3 organ toxicity, or grade 4 transaminitis|'
  expected_output:
    1:
      gt0005|Treatment: local::at0011|Vigilant supportive care, tocilizumab +/- corticosteroids|
      gt0006|Grade: local::at0017|Grade 3-4 CRS|

- id: Grade 4
  input:
    1:
      gt0003|Toxicity: 'local::at0006|Life-threatening symptoms: ventilator required, or grade 4 organ toxicity (excluding transaminitis)|'
  expected_output:
    1:
      gt0005|Treatment: local::at0011|Vigilant supportive care, tocilizumab +/- corticosteroids|
      gt0006|Grade: local::at0017|Grade 3-4 CRS|

- id: Grade 5 Death
  input:
    1:
      gt0003|Toxicity: local::at0007|Death|
  expected_output:
    1:
      gt0005|Treatment: local::at0012|Not applicable|
      gt0006|Grade: local::at0018|Grade 5|
